Please login to the form below

Not currently logged in
Email:
Password:

gantenerumab

This page shows the latest gantenerumab news and features for those working in and with pharma, biotech and healthcare.

Roche starts new late-stage trials of Alzheimer’s candidate

Roche starts new late-stage trials of Alzheimer’s candidate

Despite yet another failure for another amyloid-targeting drug for Alzheimer’s disease this week, Roche is pressing ahead with two large, phase III trials of its gantenerumab candidate. ... to gantenerumab as a potential new therapy for Alzheimer’s

Latest news

More from news
Approximately 3 fully matching, plus 8 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics